MaxQ AI, a clinical diagnostics intelligence platform announced that it has completed a distribution agreement with EnvoyAI, a subsidiary of TeraRecon. This partnership will give physicians access to its full Accipio intracranial hemorrhage (ICH) detection platform.
Coming out of this year’s RSNA annual meeting in Chicago, MaxQ continues to build momentum and strategic partnerships that will rapidly bring the company’s AI solutions to the acute care market. Leading up to and during RSNA, MaxQ announced distribution agreements with Samsung NeuroLogica and GE Healthcare via the company’s Smart Subscription platform.
Today’s agreement is notable as MaxQ’s partnership with EnvoyAI will enable hospitals around the world to have access to the company’s AI-enabled Accipio platform for approved commercial use in their emergency rooms and for clinical research purposes. Highly sensitive to the presence of ICH (commonly known as a brain bleed), Accipio identifies and prioritizes patients with ICH for the treating physician. Accipio Ix is the first part of the ecosystem and has received both FDA clearance and CE Mark certification. And now, leveraging TeraRecon’s Northstar AI Results Explorer, physicians can have access to both Accipio Ax and Accipio Dx for investigational-use only results.
“Our agreement with EnvoyAI will enable hospitals around the world to have access to our revolutionary AI-enabled Accipio platform for approved commercial use in their emergency rooms and for clinical research purposes,” said Chris Schnee, SVP Commercial Operations for MaxQ AI. “This partnership further accelerates the adoption of MaxQ solutions by acute care hospitals, which are TeraRecon’s core customer base. We are proud to be collaborating commercially with a market share leader in radiology advanced visualization. With Accipio Ix™ having both FDA clearance and CE Mark certification, U.S. and E.U. patients are soon to receive the benefit of augmented intelligence; the combination of the MaxQ AI empowerment coupled with the skills of the caregiver. Better together.”
